首页/数据集/Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer

Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer

ChEBI2012-05-02 更新2026-07-21 收录

靶向治疗响应分析

卵巢癌分子机制

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-31432 数据链接链接失效反馈

官方服务：

资源简介：

Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer

应用场景：

创建时间：

2012-05-02

癌症信号通路

卵巢癌分子机制

Supplementary Table 1. GALNT14 regulates ferroptosis and apoptosis of ovarian cancer through EGFR/mTOR pathwayThe clinical characteristics of patients with ovarian cancer Supplementary Table 2. GALN

NIAID Data Ecosystem70

Changes in mRNA/protein expression and signaling pathways in in vivo passaged mouse ovarian cancer cells

卵巢癌分子机制

肿瘤RNA-seq分析

The cure rate for late stage epithelial ovarian cancer (EOC) has not significantly improved over several decades. New and more effective targets and treatment modalities are urgently needed. RNA-seq a

NIAID Data Ecosystem50

The whole transcriptome expression profiling of human SKOV3 comparison between control and CtBP1 KD, ctbp2 KD and CTBP1/2 DKD.

卵巢癌分子机制

转录组功能分析

To discover the regulatory role of CTBP1/2 in high grade serous ovarian cancer, The full cDNA was extracted from SKOV3 shRNA control and CtBP1/2 knockdown and then compared the expression profiles

NIAID Data Ecosystem40

External RNA-seq dataset for manuscript entitled "Downregulated dual-specificity protein phosphatase 1 in ovarian carcinoma: a comprehensive study with multiple methods"

卵巢癌分子机制

RNA测序基因表达分析

RNA-seq dataset of ovarian cancer from TCGA and normal ovary from GTEx database

NIAID Data Ecosystem60

Supplementary Table 1a from miR-450a Acts as a Tumor Suppressor in Ovarian Cancer by Regulating Energy Metabolism

卵巢癌分子机制

miRNA靶标预测

Supplementary Table 1a. List of potential total miRNA and miR-450a only binding sites from A2780 control cell line

NIAID Data Ecosystem50